{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:21:34Z","timestamp":1780086094296,"version":"3.54.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s12325-018-0698-9","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T07:15:11Z","timestamp":1524467711000},"page":"591-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Efficacy and Safety of Current Interventions for Choroidal Neovascularization Associated with Rare Diseases: A Systematic Literature Review"],"prefix":"10.1007","volume":"35","author":[{"given":"Natalie","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokho","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishkarsh","family":"Likhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumjhum","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried M.","family":"Amoaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"issue":"4","key":"698_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archopht.122.4.477","volume":"122","author":"N Congdon","year":"2004","unstructured":"Congdon N, O\u2019Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477\u201385.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"698_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eurger.2014.09.007","volume":"6","author":"K Michalska-Ma\u0142ecka","year":"2015","unstructured":"Michalska-Ma\u0142ecka K, Kabiesz A, Nowak M, et al. Age related macular degeneration\u2013challenge for future: pathogenesis and new perspectives for the treatment. Eur Geriatr Med. 2015;6(1):69\u201375.","journal-title":"Eur Geriatr Med."},{"issue":"3","key":"698_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","volume":"137","author":"HE Grossniklaus","year":"2004","unstructured":"Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol. 2004;137(3):496\u2013503.","journal-title":"Am J Ophthalmol"},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res. 2015;49:67\u201381.","journal-title":"Prog Retin Eye Res."},{"issue":"8","key":"698_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","volume":"103","author":"SY Cohen","year":"1996","unstructured":"Cohen SY, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103(8):1241\u20134.","journal-title":"Ophthalmology"},{"issue":"4","key":"698_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0974-9233.58422","volume":"16","author":"P Neri","year":"2009","unstructured":"Neri P, Lettieri M, Fortuna C, et al. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. 2009;16(4):245\u201351.","journal-title":"Middle East Afr J Ophthalmol."},{"issue":"10","key":"698_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/eye.2013.155","volume":"27","author":"P Rishi","year":"2013","unstructured":"Rishi P, Gupta A, Rishi E, et al. Choroidal neovascularization in 36 eyes of children and adolescents. Eye (Lond). 2013;27(10):1158\u201368.","journal-title":"Eye (Lond)."},{"issue":"1","key":"698_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archopht.123.1.78","volume":"123","author":"Submacular Surgery Trials Research Group","year":"2005","unstructured":"Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: submacular Surgery Trials Report No. 5. Arch Ophthalmol. 2005;123(1):78\u201388.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"698_CR9","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.ophtha.2013.01.068","volume":"120","author":"JS Wittenborn","year":"2013","unstructured":"Wittenborn JS, Zhang X, Feagan CW, et al. The economic burden of vision loss and eye disorders among the United States population younger than 40 years. Ophthalmology. 2013;120(9):1728\u201335.","journal-title":"Ophthalmology"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/OPTH.S113414","volume":"11","author":"GA Garcia","year":"2017","unstructured":"Garcia GA, Khoshnevis M, Gale J, et al. Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clin Ophthalmol. 2017;11:417\u201327.","journal-title":"Clin Ophthalmol."},{"key":"698_CR11","doi-asserted-by":"crossref","unstructured":"Kozousek. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group. Arch Ophthalmol. 1994;112(9):1166\u201373.","DOI":"10.1001\/archopht.1994.01090210050016"},{"key":"698_CR12","unstructured":"Ajello L. Distribution of histoplasma capsulatum in the United States. In: Ajello L, Chick EW, Furcolow MF, editors. Histoplasmosis. IL: Springfield; 1971. p. 103\u201322."},{"issue":"3","key":"698_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0002-9394(81)90283-X","volume":"91","author":"SL Fine","year":"1981","unstructured":"Fine SL, Owens SL, Haller JA, et al. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol. 1981;91(3):318\u201322.","journal-title":"Am J Ophthalmol"},{"key":"698_CR14","doi-asserted-by":"crossref","unstructured":"Baxter SL, Pistilli M, Pujari SS, et al. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013;156(3):468\u201377 e2.","DOI":"10.1016\/j.ajo.2013.04.040"},{"issue":"12","key":"698_CR15","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1001\/archopht.1984.01040031440019","volume":"102","author":"RF Dreyer","year":"1984","unstructured":"Dreyer RF, Gass DJ. Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis. Arch Ophthalmol. 1984;102(12):1776\u201384.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"698_CR16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0161-6420(86)33611-X","volume":"93","author":"CM Morgan","year":"1986","unstructured":"Morgan CM, Schatz H. Recurrent multifocal choroiditis. Ophthalmology. 1986;93(9):1138\u201347.","journal-title":"Ophthalmology"},{"issue":"7","key":"698_CR17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0161-6420(96)30561-7","volume":"103","author":"J Brown Jr","year":"1996","unstructured":"Brown J Jr, Folk JC, Reddy CV, et al. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996;103(7):1100\u20135.","journal-title":"Ophthalmology"},{"issue":"5","key":"698_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0002-9394(84)90243-5","volume":"98","author":"RC Watzke","year":"1984","unstructured":"Watzke RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol. 1984;98(5):572\u201384.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"698_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0161-6420(96)30645-3","volume":"103","author":"CV Reddy","year":"1996","unstructured":"Reddy CV, Brown J Jr, Folk JC, et al. Enlarged blind spots in chorioretinal inflammatory disorders. Ophthalmology. 1996;103(4):606\u201317.","journal-title":"Ophthalmology"},{"issue":"5","key":"698_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/bjo.59.5.257","volume":"59","author":"JA Shields","year":"1975","unstructured":"Shields JA, Federman JL, Tomer TL, et al. Angioid streaks. I. Ophthalmoscopic variations and diagnostic problems. Br J Ophthalmol. 1975;59(5):257\u201366.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"698_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bjo.74.10.579","volume":"74","author":"TR Dabbs","year":"1990","unstructured":"Dabbs TR, Skjodt K. Prevalence of angioid streaks and other ocular complications of Paget\u2019s disease of bone. Br J Ophthalmol. 1990;74(10):579\u201382.","journal-title":"Br J Ophthalmol"},{"issue":"44","key":"698_CR22","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1073\/pnas.0905010106","volume":"106","author":"M Saint-Geniez","year":"2009","unstructured":"Saint-Geniez M, Kurihara T, Sekiyama E, et al. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA. 2009;106(44):18751\u20136.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"698_CR23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","volume":"167","author":"AG Marneros","year":"2005","unstructured":"Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005;167(5):1451\u20139.","journal-title":"Am J Pathol"},{"issue":"3","key":"698_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00941723","volume":"235","author":"T Ishibashi","year":"1997","unstructured":"Ishibashi T, Hata Y, Yoshikawa H, et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1997;235(3):159\u201367.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"698_CR25","first-page":"3158","volume":"41","author":"N Kwak","year":"2000","unstructured":"Kwak N, Okamoto N, Wood JM, et al. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41(10):3158\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"698_CR26","first-page":"34","volume":"5","author":"PA Campochiaro","year":"1999","unstructured":"Campochiaro PA, Soloway P, Ryan SJ, et al. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis. 1999;5:34.","journal-title":"Mol Vis."},{"issue":"9","key":"698_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/IAE.0b013e31818358b2","volume":"28","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Chan KP, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina. 2008;28(9):1308\u201313.","journal-title":"Retina."},{"issue":"7","key":"698_CR28","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1167\/iovs.02-1092","volume":"44","author":"JM Rakic","year":"2003","unstructured":"Rakic JM, Lambert V, Devy L, et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44(7):3186\u201393.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"698_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ajo.2004.11.064","volume":"139","author":"R Hera","year":"2005","unstructured":"Hera R, Keramidas M, Peoc\u2019h M, et al. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am J Ophthalmol. 2005;139(4):589\u201396.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"698_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000455271","volume":"237","author":"AG Shchuko","year":"2017","unstructured":"Shchuko AG, Zaitseva NV, Yurieva TN, et al. Intraocular cytokines and their correlations with clinical parameters in patients with myopic choroidal neovascularization. Ophthalmologica. 2017;237(2):96\u2013104.","journal-title":"Ophthalmologica."},{"issue":"1","key":"698_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/mvre.2002.2407","volume":"64","author":"A Otani","year":"2002","unstructured":"Otani A, Takagi H, Oh H, et al. Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res. 2002;64(1):162\u20139.","journal-title":"Microvasc Res"},{"issue":"1\u20132","key":"698_CR32","first-page":"173","volume":"441","author":"X Fan","year":"2017","unstructured":"Fan X, Gao N, Li J, et al. Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization. Mol Cell Biochem. 2017;441(1\u20132):173\u20139.","journal-title":"Mol Cell Biochem"},{"key":"698_CR33","doi-asserted-by":"crossref","unstructured":"Wolf S, Balciuniene VJ, Laganovska G, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014;121(3):682\u201392 e2.","DOI":"10.1016\/j.ophtha.2013.10.023"},{"issue":"14","key":"698_CR34","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331.","journal-title":"N Engl J Med"},{"issue":"6","key":"698_CR35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","volume":"122","author":"Y Ikuno","year":"2015","unstructured":"Ikuno Y, Ohno-Matsui K, Wong TY, et al. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology. 2015;122(6):1220\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"698_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014;121(1):193\u2013201.","journal-title":"Ophthalmology"},{"issue":"6","key":"698_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4103\/0301-4738.36474","volume":"55","author":"S Grisanti","year":"2007","unstructured":"Grisanti S, Ziemssen F. Bevacizumab: off-label use in ophthalmology. Indian J Ophthalmol. 2007;55(6):417\u201320.","journal-title":"Indian J Ophthalmol"},{"key":"698_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/OPTH.S49437","volume":"9","author":"L Matri El","year":"2015","unstructured":"El Matri L, Chebil A, Kort F. Current and emerging treatment options for myopic choroidal neovascularization. Clin Ophthalmol. 2015;9:733\u201344.","journal-title":"Clin Ophthalmol."},{"key":"698_CR39","unstructured":"European Medicines Agency. Lucentis (ranibizumab). Available from http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000715\/human_med_000890.jsp&mid=WC0b01ac058001d124 . Accessed Nov 2017."},{"key":"698_CR40","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. The Cochrane Collaboration. 2011. Available from: http:\/\/www.handbook.cochrane.org ."},{"key":"698_CR41","unstructured":"National Institute for Health and Care Excellence. Identifying the evidence: literature searching and evidence submission. In: Developing NICE guidelines: the manual. 2014. Available from: https:\/\/www.nice.org.uk\/process\/pmg20\/chapter\/introduction-and-overview ."},{"key":"698_CR42","unstructured":"National Institute for Health and Care Excellence. Appendix H Appraisal checklists, evidence tables, GRADE and economic profiles. In: Developing NICE guidelines: the manual. 2014; Available from: https:\/\/www.nice.org.uk\/process\/pmg20\/chapter\/introduction-and-overview ."},{"key":"698_CR43","unstructured":"Gilhotra JS, Vote B, Hykin P, et al. Efficacy and safety of ranibizumab 0.5\u00a0Mg in adult patients with visual impairment due to choroidal neovascularization associated with rare diseases: 12\u00a0month results of the Minerva study. In: Clinical and experimental ophthalmology; 2016. p. 123."},{"issue":"5","key":"698_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/bjo.2006.103135","volume":"91","author":"A Giovannini","year":"2007","unstructured":"Giovannini A, Neri P, Mercanti L, et al. Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation. Br J Ophthalmol. 2007;91(5):620\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"698_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/archophthalmol.2010.205","volume":"128","author":"MB Parodi","year":"2010","unstructured":"Parodi MB, Iacono P, Kontadakis DS, et al. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis. Arch Ophthalmol. 2010;128(9):1100\u20133.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"698_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3928\/23258160-20121221-07","volume":"44","author":"KJ Ramaiya","year":"2013","unstructured":"Ramaiya KJ, Blinder KJ, Ciulla T, et al. Ranibizumab versus photodynamic therapy for presumed ocular histoplasmosis syndrome. Ophthalmic Surg Lasers Imaging Retina. 2013;44(1):17\u201321.","journal-title":"Ophthalmic Surg Lasers Imaging Retina."},{"key":"698_CR47","doi-asserted-by":"crossref","unstructured":"Lai TYY, Staurenghi G, Lanzetta P, et al. Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA study. Retina. 2017 [Epub ahead of print].","DOI":"10.1097\/IAE.0000000000001744"},{"key":"698_CR48","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","volume":"114","author":"RW Beck","year":"2007","unstructured":"Beck RW, Maguire MG, Bressler NM, et al. Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology. 2007;114:1804\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"698_CR49","doi-asserted-by":"publisher","first-page":"e007746","DOI":"10.1136\/bmjopen-2015-007746","volume":"5","author":"A Stuart","year":"2015","unstructured":"Stuart A, Ford JA, Duckworth S, et al. Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review. BMJ Open. 2015;5(4):e007746.","journal-title":"BMJ Open"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-018-0698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T06:39:52Z","timestamp":1720247992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-018-0698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0698-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}